Results 61 to 70 of about 38,436 (213)

Acromegaly at diagnosis in 3173 patients from the Liège Acromegaly Survey (LAS) Database

open access: yesEndocrine-Related Cancer, 2017
Acromegaly is a rare disorder caused by chronic growth hormone (GH) hypersecretion. While diagnostic and therapeutic methods have advanced, little information exists on trends in acromegaly characteristics over time.
P. Pétrossians   +24 more
semanticscholar   +1 more source

Evidence‐based management strategies for endocrine complications after pituitary adenoma surgery

open access: yesIbrain, EarlyView.
Based on the PIPOST (Population, Intervention, Professional, Outcome, Setting, and Type of Evidence) framework, evidence‐based medicine questions were developed, and a top‐down search was conducted according to the 6S model of the evidence pyramid. The literature sources were best practices, guidelines, expert consensuses, systematic reviews, meta ...
Xiaoju Miao   +7 more
wiley   +1 more source

Unexplained massive pulmonary embolism in acromegaly patient: A case report

open access: yesClinical Case Reports
Key Clinical Message Our case highlights the importance of recognizing acromegaly as a potential risk factor for venous thromboembolism (VTE). Despite a thorough thrombophilia workup yielding unremarkable results, further research is warranted to ...
Usamah Al‐Anbagi   +3 more
doaj   +1 more source

Luteinizing hormone receptor knockout mouse: What has it taught us?

open access: yesAndrology, EarlyView.
Abstract Luteinizing hormone (LH), along with its agonist choriongonadotropin (hCG) in humans, is the key hormone responsible for the tropic regulation of the gonadal function. LH and hCG act through their cognate receptor, the luteinizing hormone/choriongonadotropin receptor (LHCGR; more appropriately LHR in rodents lacking CG), located in the testis ...
Ilpo T. Huhtaniemi
wiley   +1 more source

Clinical and biochemical characteristics of patients with acromegaly and normal or increased prolactin levels

open access: yesAlʹmanah Kliničeskoj Mediciny
Background: Prevalence of hyperprolactinemia in patients with acromegaly is 30 to 40%. Since recently, the necessity of screening for acromegaly in hyperprolactinemic patients with pituitary adenoma has been actively debated. The literature on this issue
Yuliya A. Kukushkina   +1 more
doaj   +1 more source

Stereotactic Radiosurgery for Acromegaly: An International Multicenter Retrospective Cohort Study

open access: yesNeurosurgery, 2019
BACKGROUND Stereotactic radiosurgery (SRS) is a treatment option for persistent or recurrent acromegaly secondary to a growth hormone secreting pituitary adenoma, but its efficacy is inadequately defined.
D. Ding   +22 more
semanticscholar   +1 more source

Patient Participation in Urine Specific Gravity Screening for Arginine Vasopressin Deficiency in an Inpatient Neurosurgical Clinic

open access: yesClinical Endocrinology, EarlyView.
ABSTRACT Objective Detecting hypotonic urine (specific gravity < 1005 g/L) is crucial for the early identification of arginine vasopressin deficiency (AVP‐deficiency), a common complication after pituitary surgery. This study aimed to evaluate the agreement between urine specific gravity measurements taken by patients using urine test strips and those ...
Jeanne‐Marie Nollen   +7 more
wiley   +1 more source

BACKGROUND CHANGES OF THE DIGESTIVE SYSTEM MUCOSA IN PATIENTS WITH ACROMEGALY

open access: yesAlʹmanah Kliničeskoj Mediciny, 2016
Background: Gastrointestinal tract lesions due to the growth hormone impact on mucosa of both the stomach and colon contribute to the complications of acromegaly.
A. A. Titaeva   +4 more
doaj   +1 more source

Aneurysmal dilation of sinus of Valsalva in a patient with undiagnosed acromegaly

open access: yesClinical Case Reports, 2023
Key Clinical Message In patients presenting with aortic ectasia and myxomatous valve diseases at young ages, possible underlying acromegaly should be in mind. Abstract Acromegaly is a chronic systemic disease mainly caused by the benign pituitary adenoma
Hoda Gharoy   +4 more
doaj   +1 more source

An overview of insulin therapy for the non‐specialist

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Nearly all health professionals, whatever their practice or speciality, now have contact with a significant number of insulin‐using people with diabetes. People with type 1 diabetes are nearly universally managed on more complex insulin regimens, increasingly with complex support technology, and with some understanding of the concepts ...
Philip D. Home
wiley   +1 more source

Home - About - Disclaimer - Privacy